Premium
Response to “Pharmacogenetics of Voriconazole: CYP2C19 but Also CYP3A4 Need to Be Genotyped” ‐ The Role of CYP3A4 and CYP3A5 Polymorphisms in Clinical Pharmacokinetics of Voriconazole
Author(s) -
Walsh TJ,
Moriyama B,
Penzak SR,
Klein TE,
Caudle KE
Publication year - 2017
Publication title -
clinical pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.941
H-Index - 188
eISSN - 1532-6535
pISSN - 0009-9236
DOI - 10.1002/cpt.681
Subject(s) - medicine , pharmacy , pharmacogenomics , voriconazole , oncology , family medicine , pharmacology , antifungal , dermatology